{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:09:06Z","timestamp":1787792946627,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The American Gastroenterological Association and European Association for the Study of the Liver recommend that hepatitis B surface antigen (HBsAg)\u2013negative and hepatitis B core antibody (anti-HBc)\u2013positive patients who receive immunosuppression should be monitored for hepatitis B virus (HBV) infection regardless of hepatitis B surface antibody (anti-HBs) status. However, anti-HBs may provide protection against infection. To investigate whether the presence of anti-HBs in addition to anti-HBc confers protection, we classified HBsAg(\u2212) kidney transplantation (KT) patients into 4 groups according to anti-HBc and anti-HBs status, and compared the HBV infection rate between the anti-HBc(+)anti-HBs(+) group and the other 3 groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this single-center retrospective study, we classified 1959 patients into 4 groups: anti-HBc(\u2212)anti-HBs(\u2212) (n = 356), anti-HBc(\u2212)anti-HBs(+) (n = 652), anti-HBc(+)anti-HBs(\u2212) (n = 142), and anti-HBc(+)anti-HBs(+) (n = 809).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Hepatitis B virus infection was noted in 31 (1.6%) patients after KT. There was a significant difference in HBV infection rate between anti-HBc(+)anti-HBs(+) (1.2%) and anti-HBc(+)anti-HBs(\u2212) (5.6%) (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), but not between anti-HBc(+)anti-HBs(+) and anti-HBc(\u2212)anti-HBs(\u2212) (1.1%) or anti-HBc(\u2212)anti-HBs(+) (1.4%). There was a significant difference in HBV infection rate according to anti-HBs titer, but no difference according to the donor viral profile. Hepatic failure occurred in 1 anti-HBc(+)anti-HBs(\u2212) patient and 1 anti-HBc(+)anti-HBs(+) patient, both of whom died. Hepatocellular carcinoma was noted in 4 anti-HBc(\u2212) patients, but not in anti-HBc(+) patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The presence of anti-HBs confers protection against HBV infection. We recommend monitoring for HBV infection after KT in HBsAg(\u2212) anti-HBc(+) anti-HBs(\u2212) patients, but not in HBsAg(\u2212) anti-HBc(+) anti-HBs(+) patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002173","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T16:14:17Z","timestamp":1523031257000},"page":"1717-1723","source":"Crossref","is-referenced-by-count":20,"title":["Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen\u2013negative Patients Undergoing Kidney Transplantation"],"prefix":"10.1097","volume":"102","author":[{"given":"Jae Wan","family":"Jeon","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Mi","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Dankook University Hospital, Dankook University, College of Medicine, Cheonan, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungjin","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Hee","family":"Baek","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyosang","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of General Surgery, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duck Jong","family":"Han","sequence":"additional","affiliation":[{"name":"Department of General Surgery, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.TP.0000161250.83392.73","article-title":"Natural history of hepatitis B and C in renal allograft recipients","volume":"79","year":"2005","journal-title":"Transplantation"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/tid.12065","article-title":"Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers","volume":"15","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","year":"2015","journal-title":"Gastroenterology"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00007890-199810150-00012","article-title":"Reactivation of hepatitis B after transplantation in patients with preexisting anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature","volume":"66","year":"1998","journal-title":"Transplantation"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1034\/j.1399-3062.2003.00021.x","article-title":"Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation","volume":"5","year":"2003","journal-title":"Transplant Infect Dis"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/01.TP.0000163468.80223.74","article-title":"Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation","volume":"79","year":"2005","journal-title":"Transplantation"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcv.2004.10.006","article-title":"HBV reactivation after kidney transplantation","volume":"32","year":"2005","journal-title":"J Clin Virol"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcv.2012.07.015","article-title":"Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection","volume":"55","year":"2012","journal-title":"J Clin Virol"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3109\/00365548.2012.680488","article-title":"Prevalence and clinical significance of occult hepatitis B virus infection among renal transplant recipients in Korea","volume":"44","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.transproceed.2013.01.093","article-title":"Clinical and virologic courses of hepatitis B surface antigen-negative and hepatitis B core or hepatitis B surface antibody-positive renal transplant recipients","volume":"45","year":"2013","journal-title":"Transplant Proc"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ndt\/gfw455","article-title":"Rituximab and hepatitis B reactivation in HBsAg-negative\/anti-HBc-positive kidney transplant recipients","volume":"32","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2015.04.011","article-title":"Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation","volume":"68","year":"2015","journal-title":"J Clin Virol"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00277-012-1405-6","article-title":"Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy","volume":"91","year":"2012","journal-title":"Ann Hematol"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/01.TP.0000151661.52601.FB","article-title":"Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B Virus infection","volume":"79","year":"2005","journal-title":"Transplantation"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.tp.0000189930.89031.1b","article-title":"Kidney transplantation from anti-HBc + donors: results from a retrospective Italian study","volume":"81","year":"2006","journal-title":"Transplantation"},{"key":"bib18-20231002","first-page":"S1","article-title":"KDIGO Clinical Practice Guideline on the evaluation and care of living kidney donors","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1537-2995.2010.03056.x","article-title":"Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors","volume":"51","year":"2011","journal-title":"Transfusion"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/annonc\/mdq583","article-title":"Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports","volume":"22","year":"2011","journal-title":"Ann Oncol"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/TP.0000000000001870","article-title":"Incidence of hepatitis B viral reactivation after kidney transplantation with low-dose rituximab administration","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000252780","article-title":"Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period","volume":"53","year":"2010","journal-title":"Intervirology"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3904\/kjim.2011.26.2.123","article-title":"Current status of dialysis therapy in Korea","volume":"26","year":"2011","journal-title":"Korean J Intern Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201810000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:35:32Z","timestamp":1696224932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201810000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002173","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}